Preclinical screening for retinopathy of prematurity risk using IGF1 levels at 3 weeks post-partum.
about
A predictive score for retinopathy of prematurity by using clinical risk factors and serum insulin-like growth factor-1 levels.Neuroprotective Effects of Intranasal IGF-1 against Neonatal Lipopolysaccharide-Induced Neurobehavioral Deficits and Neuronal Inflammation in the Substantia Nigra and Locus Coeruleus of Juvenile Rats.N-terminal B-type natriuretic peptide urinary concentrations and retinopathy of prematurity.
P2860
Preclinical screening for retinopathy of prematurity risk using IGF1 levels at 3 weeks post-partum.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Preclinical screening for reti ...... levels at 3 weeks post-partum.
@ast
Preclinical screening for reti ...... levels at 3 weeks post-partum.
@en
type
label
Preclinical screening for reti ...... levels at 3 weeks post-partum.
@ast
Preclinical screening for reti ...... levels at 3 weeks post-partum.
@en
prefLabel
Preclinical screening for reti ...... levels at 3 weeks post-partum.
@ast
Preclinical screening for reti ...... levels at 3 weeks post-partum.
@en
P2093
P2860
P1433
P1476
Preclinical screening for reti ...... levels at 3 weeks post-partum
@en
P2093
Alejandro Pérez-Muñuzuri
Alicia Iglesias-Deus
Ana Baña-Souto
José Blanco-Teijeiro
José María Fraga-Bermúdez
Maria Luz Couce-Pico
Olalla López-Suárez
P2860
P304
P356
10.1371/JOURNAL.PONE.0088781
P407
P577
2014-02-11T00:00:00Z